BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32206601)

  • 1. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery.
    Shariq OA; McKenzie TJ
    Gland Surg; 2020 Feb; 9(1):80-93. PubMed ID: 32206601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highlights of mechanisms and treatment of obesity-related hypertension.
    Shams E; Kamalumpundi V; Peterson J; Gismondi RA; Oigman W; de Gusmão Correia ML
    J Hum Hypertens; 2022 Sep; 36(9):785-793. PubMed ID: 35001082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-associated hypertension and kidney disease.
    Hall JE; Kuo JJ; da Silva AA; de Paula RB; Liu J; Tallam L
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):195-200. PubMed ID: 12589181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic considerations in hypertension.
    Tuck ML
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):355S-365S. PubMed ID: 2078323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.
    Kotchen TA
    Am J Hypertens; 2010 Nov; 23(11):1170-8. PubMed ID: 20706196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
    Reisin E; Jack AV
    Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes of blood pressure after weight loss: factors involved.
    Flores L; Vidal J; Núñez I; Rueda S; Viaplana J; Esmatjes E
    Surg Obes Relat Dis; 2015; 11(1):215-21. PubMed ID: 25304830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertension in obesity].
    Scholze J; Sharma AM
    Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.
    Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N
    J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome.
    Sharma AM; Engeli S
    J Cardiometab Syndr; 2006; 1(1):29-35. PubMed ID: 17675902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, hypertension, and chronic kidney disease.
    Hall ME; do Carmo JM; da Silva AA; Juncos LA; Wang Z; Hall JE
    Int J Nephrol Renovasc Dis; 2014; 7():75-88. PubMed ID: 24600241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity: A Perspective from Hypertension.
    Susic D; Varagic J
    Med Clin North Am; 2017 Jan; 101(1):139-157. PubMed ID: 27884225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric metabolic surgery.
    Scopinaro N
    Rozhl Chir; 2014 Aug; 93(8):404-15. PubMed ID: 25230385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
    Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
    Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.